Bausch & Lomb Incorporated

This Phase 2 trial tests an experimental eye drop called BL1107 against a standard treatment (timolol) in 252 adults with glaucoma or high eye pressure. Participants use the drops twice daily for 28 days. The study measures changes in vision and eye pressure to see if BL1107 is s…

This study was designed to check the long-term safety of a new eye drop that combines two active ingredients (lifitegrast and perfluorohexyloctane) for people with dry eye disease. It was a follow-up for people who had already completed an earlier study. However, the trial was wi…

This study tests a new type of artificial lens (enVista Beyond) for people having cataract surgery. The lens is designed to improve intermediate vision, like seeing a computer screen, while still providing good distance and near vision. About 304 adults will receive the lens in b…

This early-stage study tests the safety of BL1332 eye drops in 24 healthy adults aged 18 to 50. Researchers will give different strengths of the drops to find the highest dose that people can tolerate without serious side effects. The goal is to see if the drops are safe enough f…

This study tests the safety and effectiveness of the TENEO 317 excimer laser used in LASIK surgery to treat farsightedness (hyperopia) with or without astigmatism. About 140 adults aged 22 and older will receive the laser treatment in one or both eyes and be followed for 12 month…